Strengthening R&D Capabilities and Global Content Offerings
First written in FY2016. 16 of 32 entries say "Restated". Latest entry: FY2026.
56 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥75,372 million. The Group's R&D activities by major segment are as follows.」
The Group continued its policy of treating R&D as its most important management priority, and R&D expenses increased from ¥60,722 million in the previous fiscal year to ¥75,372 million. - 2026-05-12AdvancedEarnings presentation
「R&D expenses and content production costs」
Consolidated R&D expenses and content production costs increased from ¥83.3 billion in FY2025/3 to ¥98.8 billion in FY2026/3. The disclosures combine R&D expenses and content production costs. - FY2026-H1AdvancedAnnual report
「Total R&D expenses for the current interim consolidated fiscal period were ¥30,478 million.」
R&D expenses increased from ¥30,014 million in the same period of the previous fiscal year to ¥30,478 million, as the Group continued and expanded its R&D activities. - FY2025RestatedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥60,722 million. The Group's R&D activities by major segment are as follows.」
The Group continued its policy of treating the strengthening of R&D as an important management priority and recorded R&D expenses of ¥6,072.2 million. - FY2025-H1AdvancedAnnual report
「Total R&D expenses for the current interim consolidated fiscal period were ¥30,014 million.」
The Group continued its R&D activities and recorded total R&D expenses of ¥30,014 million for the interim period. - FY2024AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥61,365 million.」
The Group continued its policy of treating R&D as its most important priority, and R&D expenses increased from ¥51,410 million in the previous fiscal year to ¥61,365 million. - FY2024-Q3AdvancedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥45,944 million.」
The Group continued its R&D activities, and R&D expenses increased from ¥38,198 million in the same period of the previous fiscal year to ¥45,944 million. - FY2024-Q2AdvancedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥27,426 million.」
The Group continued its R&D activities, and R&D expenses increased from ¥24,323 million in the same period of the previous fiscal year to ¥27,426 million. - FY2024-Q1AdvancedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥12,048 million.」
The Group continued its R&D activities and recorded total R&D expenses of ¥12,048 million for the first quarter, up from ¥10,885 million in the same period of the previous fiscal year. - FY2023AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥51,410 million. The Group's R&D activities by major segment are as follows.」
The Group continued its policy of treating R&D as its most important priority, and R&D expenses increased from ¥47,127 million in the previous fiscal year to ¥51,410 million. - FY2023-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥38,198 million.」
The Group continued its R&D activities and recorded R&D expenses of ¥3,819.8 million for the cumulative third quarter of the current consolidated fiscal year. - FY2023-Q2AdvancedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥24,323 million.」
The Group continued its R&D activities, and R&D expenses increased from ¥21,504 million in the same period of the previous fiscal year to ¥24,323 million. - FY2023-Q1AdvancedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥11,812 million.」
The Group continued its R&D activities, and R&D expenses for the current quarter increased from ¥10,885 million in the same period of the previous fiscal year to ¥11,812 million. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥21,504 million.」
The Group continued its R&D activities and recorded R&D expenses of ¥2,150.4 million for the cumulative second quarter of the current consolidated fiscal year. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥10,885 million.」
The Group continued its R&D activities and recorded R&D expenses of ¥1,088.5 million in the first quarter. - FY2021AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥48,285 million.」
The Group continued its policy of treating R&D as its most important priority, and R&D expenses increased from ¥46,782 million in the previous fiscal year to ¥48,285 million. - FY2021-Q1AdvancedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥12,411 million.」
The Group continued its R&D activities and recorded total R&D expenses of ¥12,411 million, up from ¥11,409 million in the same period of the previous fiscal year. - FY2020-Q3AdvancedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥37,436 million.」
R&D expenses for the cumulative third quarter were ¥37,436 million, up from ¥33,614 million in the same period of the previous fiscal year. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥23,675 million.」
The Group continued its R&D activities and recorded total R&D expenses of ¥23,675 million for the cumulative second quarter of the current consolidated fiscal year. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥11,409 million.」
The Group continued its R&D activities and recorded total R&D expenses of ¥11,409 million for the first quarter. - FY2019AdvancedAnnual report
「As a global, integrated entertainment company, the Group is treating the strengthening and enhancement of research and development as one of its most important management priorities. Total R&D expenses for the current consolidated fiscal year were ¥46,782 million.」
The Group continued its policy of treating R&D as its most important priority, and R&D expenses increased from ¥43,525 million in the previous fiscal year to ¥46,782 million. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥3,361 million.」
The Group continued its R&D activities and recorded total R&D expenses of ¥3,361 million for the cumulative third quarter of the current consolidated fiscal year. - FY2019-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥2,157 million.」
The Group continued its R&D activities and recorded total R&D expenses of ¥2,157 million for the cumulative second quarter of the current consolidated fiscal year. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥1,054 million.」
The Group continued to strengthen its R&D activities and recorded total R&D expenses of ¥1,054 million for the current first quarter. - FY2018RestatedAnnual report
「As a global, integrated entertainment company, the Group is treating the strengthening and enhancement of research and development as one of its most important management priorities. Total R&D expenses for the current consolidated fiscal year were ¥4,353 million.」
The Group continued its policy of treating R&D as its most important priority and recorded annual R&D expenses of ¥4,353 million. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥3,356 million.」
The Group continued its R&D activities and reported total R&D expenses of ¥3,356 million for the cumulative third quarter. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥2,266 million.」
The Group continued its R&D activities and reported total R&D expenses of ¥2,266 million for the first half. - FY2018-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥1,062 million.」
The Group continued its R&D activities in the first quarter and recorded total R&D expenses of ¥1,062 million. - FY2017-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥3,304 million.」
The Group continues its R&D activities and reported total R&D expenses of ¥3,304 million for the cumulative third quarter. - FY2017-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥2,118 million.」
The Group continues its R&D activities and reported total R&D expenses of ¥2,118 million for the first half. - FY2017-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥1,007 million.」
The Group recorded total R&D expenses of ¥1,007 million for the first quarter and continues its R&D activities. - FY2016First statedAnnual report
「As a global, integrated entertainment company, the Group is treating the strengthening and enhancement of research and development as one of its most important management priorities.」
The Group recorded total R&D expenses of ¥4,175 million and is strengthening its development structure for amusement machines, digital games, packaged games, amusement equipment and resort facilities.